郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Central and Peripheral Glucagon Reduces Hyperlipidemia in Rats and Hamsters.

期刊：Drug research发表年份：2017作者：Vishal Patel; Amit Joharapurkar; Samadhan Kshirsagar; Hiren M Patel; Dheerendra Pandey; Dipam Patel; Kiran Shah; Rajesh Bahekar; Gaurang B Shah; Mukul R Jain
阅读更多 →

药效评价Interspecies homology of cytochrome P-450: inhibition by anti-P-450-male antibodies of testosterone hydroxylases in liver microsomes from various animal species including man.

期刊：Japanese journal of pharmacology发表年份：1989作者：T Miura; H Shimada; H Ohi; M Komori; T Kodama; T Kamataki
阅读更多 →

药效评价Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside).

期刊：Journal of lipid research发表年份：1993作者：H J Harwood; C E Chandler; L D Pellarin; F W Bangerter; R W Wilkins; C A Long; P G Cosgrove; M R Malinow; C A Marzetta; J L Pettini
阅读更多 →

药效评价Activity of pentamidine-containing human red cell ghosts against visceral leishmaniasis in the hamster.

期刊：The American journal of tropical medicine and hygiene发表年份：1986作者：J D Berman; J V Gallalee; J S Williams; W D Hockmeyer
阅读更多 →